share_log

Reviva Pharmaceuticals | 10-K/A: FY2019 Annual Report

SEC announcement ·  May 7, 2021 17:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more